Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Escalade (ESCA) Capital Expenditures (2016 - 2026)

Escalade's Capital Expenditures history spans 17 years, with the latest figure at $848000.0 for Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 56.17% to $848000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $2.8 million, a 26.66% increase, with the full-year FY2025 number at $2.5 million, up 23.26% from a year prior.
  • Capital Expenditures hit $848000.0 in Q1 2026 for Escalade, down from $1.2 million in the prior quarter.
  • Over the last five years, Capital Expenditures for ESCA hit a ceiling of $1.2 million in Q4 2025 and a floor of $256000.0 in Q4 2022.
  • Historically, Capital Expenditures has averaged $564352.9 across 5 years, with a median of $517000.0 in 2023.
  • Biggest five-year swings in Capital Expenditures: plummeted 93.6% in 2022 and later surged 124.45% in 2024.
  • Tracing ESCA's Capital Expenditures over 5 years: stood at $319000.0 in 2022, then surged by 62.07% to $517000.0 in 2023, then rose by 7.54% to $556000.0 in 2024, then skyrocketed by 123.92% to $1.2 million in 2025, then plummeted by 31.89% to $848000.0 in 2026.
  • Business Quant data shows Capital Expenditures for ESCA at $848000.0 in Q1 2026, $1.2 million in Q4 2025, and $291000.0 in Q3 2025.